Key result
Overexpression of nucleotide sequence-modified NSP2 and NSP5 enabled the rapid and efficient production of recombinant rotaviruses, facilitating the establishment of molecular clones of clinical isolates.
Why the study?
Challenges persist in generating rotavirus clinical strains and recombinant viruses with low replication capacities using reverse genetics systems.
An improved reverse genetics system using modified NSP2 and NSP5 genes allows for efficient generation of recombinant rotaviruses, facilitating the study of viral pathogenesis.
Modified NSP2/NSP5 overexpression enables rapid recombinant RV rescue; leaves open translation to clinical virology.
Reverse genetics systems for rotaviruses (RV) facilitate the generation of genetically engineered RVs by transfection of 11 plasmids encoding 11 genomic viral RNA segments. In addition to viral genome expression, overexpression of NSP2 and NSP5 has been used to increase the rescue efficiency of recombinant RVs. Here, we showed that the overexpression of nucleotide sequence-modified NSP2 and NSP5 enabled the rapid and efficient production of recombinant RVs. Using improved reverse genetics, we established a reverse genetics system for human and bovine RV clinical isolates, as well as laboratory strains of bovine RV (NCDV and UK) and porcine RV (Gottfried). In addition, we rescued low-replicating recombinant RVs carrying a mutant NSP4 lacking the double-layered particle-binding domain, which was deficient in the efficient production of mature virions. These advancements in reverse genetics enabled the generation of molecular clones of RV clinical isolates and recombinant RVs harboring critical amino acid mutations, offering a versatile platform for investigating RV biology and pathogenesis.IMPORTANCERecombinant rotavirus (RV) synthesis via reverse genetics relies on both the viral propagation capacity and the efficiency of the experimental system. Since the establishment of our reverse genetics system, several enhancements have been implemented to augment the rescue efficiency. Nevertheless, challenges persist in generating RV clinical strains and recombinant viruses with low replication capacities. Notably, this improved reverse genetics system successfully facilitated the establishment of molecular clones of human and bovine RV clinical isolates. Fecal samples from patients with RV typically harbor quasi-species or, occasionally, multiple genotypes of RV. In the present study, we performed the genetic sequencing of clinical viral strains during the early propagation stages in cultured cells. Subsequently, infectious viruses were synthesized, allowing the characterization of circulating viruses in nature. This approach provides valuable insights into the genetic diversity and dynamics of RV populations and contributes to a more comprehensive understanding of viral pathogenesis and evolution.
No takes yet. Share an insight, caveat, or question.
Kanai et al. (2024) studied Rotavirus. Overexpression of nucleotide sequence-modified NSP2 and NSP5 was evaluated on Production of recombinant rotaviruses. Overexpression of nucleotide sequence-modified NSP2 and NSP5 enabled the rapid and efficient production of recombinant rotaviruses, facilitating the establishment of molecular clones of clinical isolates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: